Live Breaking News & Updates on Clinical Trial Design

Stay updated with breaking news from Clinical trial design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top Kidney Patient Group Shares National Reuters Pharma Award

/PRNewswire/ The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient organization in the U.S., and Bayer were. ....

United States , University Of Washington , New Market , Department Of Defense , Reuters Pharma Award In Driving Health Equity , University Of Minnesota Hennepin Healthcare Research Institute , University Of Pittsburgh , Centers For Disease , Patient Research , Health Resources , National Institutes Of Health , Northwestern University , Vanderbilt University , Centers For Medicare , Order On Advancing American Kidney Health , Health Sciences , University Of Pennsylvania , University Of California Los Angeles , Medicaid Services , National Institute Of Diabetes , George Washington University School Of Medicine , Government Determinants Of Health Gdo , Standing Patient Council , Emory University , Wake Forest University , Us Congress ,

4th Annual Psychedelic Therapeutics and Drug Development Conference Scheduled for May 23-24 in Boston, MA

4th Annual Psychedelic Therapeutics and Drug Development Conference Scheduled for May 23-24 in Boston, MA
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Alan Kozikowski , Deborah Mash , Charles Nichols , Los Angeles , Purminds Neuropharma , Peter Hendricks , Bernard Lerer , Drug Development Conference , Precision Medicine To Mental Health Care , University Of Alabama Birmingham , Legal Challenges In Research , Corporate Communications , Reimagining The Framework For Psychedelic Research , Hebrew University , Revere Hotel Boston Common , Life Sciences , Health Sciences Center , University Of Miami Miller School Medicine , Department Of Psychiatry , Arrowhead Sci Tech Conferences , Psychedelic Therapeutics , Clinical Trial Design , Intellectual Property , Regulatory Guidance , Psychedelic Drug Delivery ,

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translati. ....

Colorado Convention Center , United States , Marcio Souza , American Academy Of Neurology , Praxis Precision Medicines Inc , Exchange Commission , Program To Evaluate The Efficacy , Tremor Program , Precision Medicines , American Academy , Colorado Convention , Clinical Trial Design , Exhibit Hall , Neurologic Care Industry Presentation , Decentralized Phase , Praxi Phase , Ulixacaltamide Treatment , Essential Tremor , Concomitant Propranolol , Four Seasons , Praxi Cerebrum , Private Securities Litigation Reform Act , Annual Report , Although Praxi ,

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it plans to move forward with its intravenous formulation of its AP-188 (“N,N-Dimethyltryptamine” or “DMT”) stroke research program as its lead asset, after having sold its Ifenprodil research program for USD $2M cash and a 20% common share ....

British Columbia , United Kingdom , Christopherj Moreau , Company Or Algernon , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Centre For Human Drug Research , Company Phase , Algernon Neuroscience , Stroke Study , Human Drug Research , Algernon Pharmaceuticals Inc , Clinical Trial Design , Research Program , Algernon Neuroscience ,

Limb-Girdle Muscular Dystrophy Leaders Advance Collaborative Dialogue to Accelerate Drug Development to Address the Urgent Unmet Need in Limb-Girdle Muscular Dystrophy

/PRNewswire/ On February 8, 2024, The Speak Foundation, a patient-led 501(c)(3) organization for Limb-Girdle Muscular Dystrophy (LGMD), convened a. ....

United States , Douglas Sproule , Michelle Campbell , Matthew Wicklund , Jannie Kennedy , Katherine Mathews , Kathryn Bryant Knudson , Nicholas Johnson , Peter Marks , Louise Rodino Klapac , Nicole Verdun , Lindsay Alfano , Peter Kang , Peter Stein , James Signorovitch , Jerryr Mendell , Drug Administration , Office Of New Drugs , Everylife Foundation For Rare Diseases , University Of Minnesota Medical School , University Of Texas San Antonio , Analysis Group , Virginia Commonwealth University , Drug Developers , Speak Foundation , University Of Iowa Health Care ,